Lead Story Picture
Mylan responded to criticism over the rising costs of its EpiPen on Monday by announcing plans for a generic version. (Credit: AP)

Mylan To Release $300 EpiPen Generic After Backlash

Mylan NV will be releasing a $300 generic for its epinephrine injector EpiPen in the next few weeks, the company said Monday following harsh public scrutiny about the ever-increasing price of the emergency allergy medication. 

  • Fed Wants $1.2M Fine And Ban For Ex-Barclays Forex Trader

    Barclays PLC's former global head of its foreign exchange spot business should be fined $1.2 million and banned from the banking industry after using chat rooms with competitors to manipulate the market, the Federal Reserve Board said Monday.

  • BREAKING: Ex-Chicago Official Gets 10 Years For Taking Bribes

    A former Chicago transportation official convicted of accepting bribes from a notorious city contractor was sentenced to 10 years in prison by an Illinois federal judge on Monday.

  • BREAKING: Andrews Kurth Brings On Attys Of Struggling Kenyon & Kenyon

    Andrews Kurth LLP has snapped up the attorneys who remained at struggling intellectual property boutique Kenyon & Kenyon LLP, the firm said Monday, in a deal that brings 55 additional intellectual property attorneys into the fold of the Houston-based international law firm.

  • HSBC To Pay $13M To End Privacy Row Over Recorded Calls

    HSBC Card Services Inc. has agreed to pay $13 million to resolve a consolidated proposed class action accusing the company of unlawfully recording debt-collection calls without the consent of consumers, according to documents filed Friday in California federal court.

  • Aeropostale's Future In Doubt As Auction Looms

    The future of retailer Aeropostale appeared in doubt on Friday after the company’s attorney said it has received multiple bids to liquidate the business and a New York judge refused its request to limit leverage of lender Sycamore Partners, which Aeropostale accused of forcing it into Chapter 11, at an upcoming auction.

  • Donald Trump Loses Bid To Block Experts In Trump U. Suit

    A California federal judge on Thursday denied Donald Trump's bid to stop two marketing and real estate education experts from testifying in a class action over the advertising strategies of the defunct, for-profit company Trump University, finding the presidential candidate’s arguments unpersuasive.



Exxon Global Warming Fight Opens New Frontier For Corporate Speech

By Ed Beeson

The oil giant’s use of the First Amendment in a bid to block government investigations into its statements about climate change is pushing the concept of corporate free speech into new territory.